Antibody Humanization Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: A9FE2FAE2140EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibody Humanization in Global, including the following market information:

Global Antibody Humanization Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antibody Humanization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibody Humanization include Accurus Biosciences, IONTAS, Lonza, Oak BioSciences, Panorama Research, PX'Therapeutics and Yurogen Biosystems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Humanization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Humanization Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antibody Humanization Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Bispecific Antibodies
• CDR Grafted Antibodies

Global Antibody Humanization Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antibody Humanization Market Segment Percentages, by Application, 2021 (%)

• HIV
• SARS
• RSV
• Prion

Global Antibody Humanization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antibody Humanization Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody Humanization revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antibody Humanization revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Accurus Biosciences
• IONTAS
• Lonza
• Oak BioSciences
• Panorama Research
• PX'Therapeutics
• Yurogen Biosystems

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Humanization Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Humanization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY HUMANIZATION OVERALL MARKET SIZE

2.1 Global Antibody Humanization Market Size: 2021 VS 2028
2.2 Global Antibody Humanization Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibody Humanization Players in Global Market
3.2 Top Global Antibody Humanization Companies Ranked by Revenue
3.3 Global Antibody Humanization Revenue by Companies
3.4 Top 3 and Top 5 Antibody Humanization Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antibody Humanization Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody Humanization Players in Global Market
  3.6.1 List of Global Tier 1 Antibody Humanization Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibody Humanization Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antibody Humanization Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Bispecific Antibodies
  4.1.4 CDR Grafted Antibodies
4.2 By Type - Global Antibody Humanization Revenue & Forecasts
  4.2.1 By Type - Global Antibody Humanization Revenue, 2017-2022
  4.2.2 By Type - Global Antibody Humanization Revenue, 2023-2028
  4.2.3 By Type - Global Antibody Humanization Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Humanization Market Size, 2021 & 2028
  5.1.2 HIV
  5.1.3 SARS
  5.1.4 RSV
  5.1.5 Prion
5.2 By Application - Global Antibody Humanization Revenue & Forecasts
  5.2.1 By Application - Global Antibody Humanization Revenue, 2017-2022
  5.2.2 By Application - Global Antibody Humanization Revenue, 2023-2028
  5.2.3 By Application - Global Antibody Humanization Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Humanization Market Size, 2021 & 2028
6.2 By Region - Global Antibody Humanization Revenue & Forecasts
  6.2.1 By Region - Global Antibody Humanization Revenue, 2017-2022
  6.2.2 By Region - Global Antibody Humanization Revenue, 2023-2028
  6.2.3 By Region - Global Antibody Humanization Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antibody Humanization Revenue, 2017-2028
  6.3.2 US Antibody Humanization Market Size, 2017-2028
  6.3.3 Canada Antibody Humanization Market Size, 2017-2028
  6.3.4 Mexico Antibody Humanization Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antibody Humanization Revenue, 2017-2028
  6.4.2 Germany Antibody Humanization Market Size, 2017-2028
  6.4.3 France Antibody Humanization Market Size, 2017-2028
  6.4.4 U.K. Antibody Humanization Market Size, 2017-2028
  6.4.5 Italy Antibody Humanization Market Size, 2017-2028
  6.4.6 Russia Antibody Humanization Market Size, 2017-2028
  6.4.7 Nordic Countries Antibody Humanization Market Size, 2017-2028
  6.4.8 Benelux Antibody Humanization Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antibody Humanization Revenue, 2017-2028
  6.5.2 China Antibody Humanization Market Size, 2017-2028
  6.5.3 Japan Antibody Humanization Market Size, 2017-2028
  6.5.4 South Korea Antibody Humanization Market Size, 2017-2028
  6.5.5 Southeast Asia Antibody Humanization Market Size, 2017-2028
  6.5.6 India Antibody Humanization Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antibody Humanization Revenue, 2017-2028
  6.6.2 Brazil Antibody Humanization Market Size, 2017-2028
  6.6.3 Argentina Antibody Humanization Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibody Humanization Revenue, 2017-2028
  6.7.2 Turkey Antibody Humanization Market Size, 2017-2028
  6.7.3 Israel Antibody Humanization Market Size, 2017-2028
  6.7.4 Saudi Arabia Antibody Humanization Market Size, 2017-2028
  6.7.5 UAE Antibody Humanization Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Accurus Biosciences
  7.1.1 Accurus Biosciences Corporate Summary
  7.1.2 Accurus Biosciences Business Overview
  7.1.3 Accurus Biosciences Antibody Humanization Major Product Offerings
  7.1.4 Accurus Biosciences Antibody Humanization Revenue in Global Market (2017-2022)
  7.1.5 Accurus Biosciences Key News
7.2 IONTAS
  7.2.1 IONTAS Corporate Summary
  7.2.2 IONTAS Business Overview
  7.2.3 IONTAS Antibody Humanization Major Product Offerings
  7.2.4 IONTAS Antibody Humanization Revenue in Global Market (2017-2022)
  7.2.5 IONTAS Key News
7.3 Lonza
  7.3.1 Lonza Corporate Summary
  7.3.2 Lonza Business Overview
  7.3.3 Lonza Antibody Humanization Major Product Offerings
  7.3.4 Lonza Antibody Humanization Revenue in Global Market (2017-2022)
  7.3.5 Lonza Key News
7.4 Oak BioSciences
  7.4.1 Oak BioSciences Corporate Summary
  7.4.2 Oak BioSciences Business Overview
  7.4.3 Oak BioSciences Antibody Humanization Major Product Offerings
  7.4.4 Oak BioSciences Antibody Humanization Revenue in Global Market (2017-2022)
  7.4.5 Oak BioSciences Key News
7.5 Panorama Research
  7.5.1 Panorama Research Corporate Summary
  7.5.2 Panorama Research Business Overview
  7.5.3 Panorama Research Antibody Humanization Major Product Offerings
  7.5.4 Panorama Research Antibody Humanization Revenue in Global Market (2017-2022)
  7.5.5 Panorama Research Key News
7.6 PX'Therapeutics
  7.6.1 PX'Therapeutics Corporate Summary
  7.6.2 PX'Therapeutics Business Overview
  7.6.3 PX'Therapeutics Antibody Humanization Major Product Offerings
  7.6.4 PX'Therapeutics Antibody Humanization Revenue in Global Market (2017-2022)
  7.6.5 PX'Therapeutics Key News
7.7 Yurogen Biosystems
  7.7.1 Yurogen Biosystems Corporate Summary
  7.7.2 Yurogen Biosystems Business Overview
  7.7.3 Yurogen Biosystems Antibody Humanization Major Product Offerings
  7.7.4 Yurogen Biosystems Antibody Humanization Revenue in Global Market (2017-2022)
  7.7.5 Yurogen Biosystems Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antibody Humanization Market Opportunities & Trends in Global Market
Table 2. Antibody Humanization Market Drivers in Global Market
Table 3. Antibody Humanization Market Restraints in Global Market
Table 4. Key Players of Antibody Humanization in Global Market
Table 5. Top Antibody Humanization Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antibody Humanization Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antibody Humanization Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antibody Humanization Product Type
Table 9. List of Global Tier 1 Antibody Humanization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Humanization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibody Humanization Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antibody Humanization Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antibody Humanization Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antibody Humanization Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antibody Humanization Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antibody Humanization Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antibody Humanization Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antibody Humanization Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antibody Humanization Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antibody Humanization Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antibody Humanization Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antibody Humanization Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antibody Humanization Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antibody Humanization Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antibody Humanization Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antibody Humanization Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antibody Humanization Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antibody Humanization Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antibody Humanization Revenue, (US$, Mn), 2023-2028
Table 30. Accurus Biosciences Corporate Summary
Table 31. Accurus Biosciences Antibody Humanization Product Offerings
Table 32. Accurus Biosciences Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 33. IONTAS Corporate Summary
Table 34. IONTAS Antibody Humanization Product Offerings
Table 35. IONTAS Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 36. Lonza Corporate Summary
Table 37. Lonza Antibody Humanization Product Offerings
Table 38. Lonza Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 39. Oak BioSciences Corporate Summary
Table 40. Oak BioSciences Antibody Humanization Product Offerings
Table 41. Oak BioSciences Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 42. Panorama Research Corporate Summary
Table 43. Panorama Research Antibody Humanization Product Offerings
Table 44. Panorama Research Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 45. PX'Therapeutics Corporate Summary
Table 46. PX'Therapeutics Antibody Humanization Product Offerings
Table 47. PX'Therapeutics Antibody Humanization Revenue (US$, Mn), (2017-2022)
Table 48. Yurogen Biosystems Corporate Summary
Table 49. Yurogen Biosystems Antibody Humanization Product Offerings
Table 50. Yurogen Biosystems Antibody Humanization Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antibody Humanization Segment by Type in 2021
Figure 2. Antibody Humanization Segment by Application in 2021
Figure 3. Global Antibody Humanization Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody Humanization Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody Humanization Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody Humanization Revenue in 2021
Figure 8. By Type - Global Antibody Humanization Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antibody Humanization Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antibody Humanization Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antibody Humanization Revenue Market Share, 2017-2028
Figure 12. US Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antibody Humanization Revenue Market Share, 2017-2028
Figure 16. Germany Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 17. France Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antibody Humanization Revenue Market Share, 2017-2028
Figure 24. China Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 28. India Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antibody Humanization Revenue Market Share, 2017-2028
Figure 30. Brazil Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antibody Humanization Revenue Market Share, 2017-2028
Figure 33. Turkey Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antibody Humanization Revenue, (US$, Mn), 2017-2028
Figure 37. Accurus Biosciences Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. IONTAS Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lonza Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Oak BioSciences Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Panorama Research Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. PX'Therapeutics Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Yurogen Biosystems Antibody Humanization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)